Mallinckrodt Competitors

Delisted . USA . 
Stock . Mallinckrodt Plc
MNKDelisted Stock  USD 0.46  0.02  4.17%   
Mallinckrodt Plc competes with Lifecore Biomedical, Shuttle Pharmaceuticals, Organogenesis Holdings, Journey Medical, and Canopy Growth; as well as few others. The company runs under Biotechnology sector within Health Care industry. Analyzing Mallinckrodt Plc competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Mallinckrodt Plc to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Mallinckrodt Plc competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.460.460.46
Details
Intrinsic
Valuation
LowRealHigh
0.440.440.51
Details
Naive
Forecast
LowNextHigh
0.060.060.06
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.411.141.87
Details

Mallinckrodt Plc Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Mallinckrodt Plc and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Mallinckrodt and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Mallinckrodt Plc does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ADMP
+ 0.98
LSDI
ACB
+ 0.85
CGC
SHPH
+ 0.82
ADMP
SHPH
+ 0.79
LSDI
CGC
+ 0.74
SHPH
ORGO
+ 0.73
LFCR
  
High negative correlations   
ACB
- 0.78
ORGO
DERM
- 0.74
ADMP
DERM
- 0.73
LSDI
CGC
- 0.65
ALIM
ADMP
- 0.65
ALIM
ALIM
- 0.61
LSDI

Risk-Adjusted Indicators

There is a big difference between Mallinckrodt Stock performing well and Mallinckrodt Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mallinckrodt Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Mallinckrodt Plc Competitive Analysis

The better you understand Mallinckrodt Plc competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Mallinckrodt Plc's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Mallinckrodt Plc's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MNK LFCR LSDI ALIM ADMP SHPH ORGO DERM CGC ACB
 4.17 
 0.46 
Mallinckrodt
 4.73 
 7.31 
Lifecore
 0.00 
 0.02 
Lucy
 0.18 
 5.54 
Alimera
 12.12 
 1.74 
Adamis
 1.14 
 0.87 
Shuttle
 0.75 
 4.05 
Organogenesis
 3.27 
 5.37 
Journey
 1.04 
 3.90 
Canopy
 0.93 
 4.34 
Aurora
Market Volatility
(90 Days Market Risk)
Very steady
Unstable
Very steady
Slightly risky
Very steady
Out of control
Very risky
Relatively risky
Very risky
Relatively risky
Market Performance
(90 Days Performance)
Very Weak
Insignificant
Very Weak
Very Weak
Very Weak
Very Weak
OK
Insignificant
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Above Average
Dangerous
Dangerous
Dangerous
Very High
Low
Low
High
Very High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Not Available
Not Available
Not Available
Not Available
Strong Buy
Strong Buy
Hold
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Not Rated
Not Rated
Not Rated
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
2.98
N/A
N/A
1.3
1.58
0.03
2.62
1.4
3.94
5.13
Net Asset
6.01 B
273.7 M
8.78 M
153.52 M
10.93 M
5.95 M
460.02 M
76.85 M
1.3 B
838.67 M
Profit Margin
-0.83
0.0509
N/A
-0.15
N/A
N/A
-0.0162
-0.32
-2.01
-0.15
EBITDA
(723.5 M)
812 K
(5.66 M)
7.28 M
(24.27 M)
(5.89 M)
36.03 M
1.92 M
(312.83 M)
20.47 M
Operating Margin
-0.0147
-0.37
-89.07
0.0786
-3.74
N/A
0.0542
-0.2
-0.34
-0.0173
Current Valuation
2.62 B
388.4 M
2.04 M
360.44 M
7.28 M
3.64 M
539.66 M
105.99 M
671.75 M
245.45 M
Price To Book
0.069
15.35
0.43
7.77
8.62
4.16
1.89
9.94
1.08
0.6
Retained Earnings
(588.2 M)
(166.52 M)
(44.42 M)
(418.49 M)
(304.56 M)
(15.49 M)
(40.97 M)
(72.36 M)
(10.33 B)
(6.37 B)
Current Asset
1.51 B
N/A
N/A
51.6 M
4.15 M
N/A
24.47 M
217.23 M
1.21 B
174.76 M
Beta
3.06
0.94
N/A
1.25
1.28
0.74
1.6
0.92
1.78
2.7
Number Of Employees
2.67 K
524
2
154
11
8
862
41
1.03 K
1.07 K
Shares Outstanding
13.29 M
36.83 M
1.76 M
54.38 M
9.36 M
3.66 M
132.58 M
14.89 M
105.36 M
54.88 M
Cash Flow From Operations
455.4 M
(217 K)
(4.27 M)
(14.26 M)
(25.9 M)
(5.58 M)
30.92 M
5.24 M
(281.95 M)
(68.51 M)
Total Debt
3.07 B
130.36 M
1.79 M
67.4 M
342.56 K
1.09 M
119.35 M
17.73 M
668 M
104.79 M
Return On Equity
-1.11
0.17
N/A
-0.35
-7.85
-1.86
-0.0266
-1.3
-0.93
-0.0579
Z Score
0.09
N/A
N/A
N/A
-33.43
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.0029
-0.0225
-0.99
0.0098
-1.04
-0.62
0.0164
-0.17
-0.0439
-0.0124
Number Of Shares Shorted
1.79 M
2.57 M
2.68 K
578.49 K
98.94 K
702.63 K
9.79 M
60.75 K
8.22 M
2.81 M
Book Value Per Share
47.06
-0.13
0.046
0.74
-4.24
2.02
2.1
0.53
5.43
0.01
Current Liabilities
1.23 B
N/A
N/A
7.85 M
2.75 M
N/A
23.22 M
25.9 M
111.3 M
105.1 M
Total Asset
6.01 B
273.7 M
8.78 M
153.52 M
10.93 M
5.95 M
460.02 M
76.85 M
1.3 B
838.67 M
Debt To Equity
1.44
N/A
N/A
N/A
0.16
0.091
0.52
0.61
0.95
0.41
Short Ratio
0.19
19.6
N/A
1.93
0.02
0.25
23.59
0.71
1.36
3.77
Target Price
1.75
8.0
35.0
5.67
0.42
N/A
4.7
10.0
6.17
32.07
Shares Owned By Institutions
96.64
69.57
7.08
86.54
16.59
1.81
48.28
14.56
8.78
13.06
Market Capitalization
4.52 M
257.05 M
906.91 K
301.29 M
7.25 M
3.23 M
532.96 M
108.63 M
510.22 M
259.17 M
Price To Earning
1.09
N/A
N/A
1.65
-6.21
N/A
17.12
-9.5
-20.08
46.94
Price To Earnings To Growth
-0.01
3.51
N/A
N/A
N/A
N/A
6.15
-0.04
-0.11
N/A
Price To Sales
0.0616
2.0
54.2
3.02
17.64
N/A
1.17
1.88
1.82
0.8
Net Income
(717.4 M)
9.33 M
(8.99 M)
(20.13 M)
(26.48 M)
(6.59 M)
4.95 M
(3.85 M)
(483.68 M)
(59.05 M)
Earnings Per Share
-0.78
0.13
-7.64
1.05
-10.14
-4.25
-0.05
-0.92
-5.09
-0.46
Shares Owned By Insiders
10.09
5.31
30.39
5.34
7.81
27.8
43.44
30.47
0.17
N/A
Revenue
2.21 B
128.26 M
7.05 K
80.75 M
4.76 M
N/A
433.14 M
79.18 M
297.15 M
270.28 M
Working Capital
1.29 B
42.16 M
1.11 M
30.51 M
(2.12 M)
4.55 M
144.53 M
14.59 M
136.47 M
301.99 M
Cash And Equivalents
1.34 B
N/A
N/A
7.86 M
8.88 M
50.44 K
113.24 M
38.14 M
1.23 B
439.14 M
Cash Per Share
26.93
N/A
N/A
1.12
0.06
N/A
0.87
2.17
2.94
1.46
Gross Profit
610 M
27.29 M
2.55 K
52 M
(1.43 M)
N/A
345.87 M
42.89 M
(81.94 M)
21.23 M
Day Typical Price
0.47
7.28
0.02
5.54
1.8
0.88
4.09
5.38
3.95
4.36
Accumulation Distribution
0.1
11125.36
N/A
0.0054
0.16
5484.66
55762.71
11429.46
232608.0
32279.55
Market Facilitation Index
0.05
0.0
N/A
0.03
0.32
0.0
N/A
0.0
N/A
N/A
Daily Balance Of Power
(0.40)
0.825
0.0
(0.33)
(0.75)
(0.17)
0.15
0.3148
0.16
0.25
Period Momentum Indicator
(0.02)
0.33
N/A
(0.01)
(0.24)
(0.01)
0.03
0.17
0.04
0.04
Rate Of Daily Change
0.96
1.05
1.0
1.0
0.88
0.99
1.01
1.03
1.01
1.01
Day Median Price
0.48
7.26
0.02
5.55
1.83
0.88
4.11
5.38
3.97
4.37
Price Action Indicator
(0.03)
0.21
N/A
(0.01)
(0.21)
(0.01)
(0.04)
0.075
(0.06)
(0.01)
Coefficient Of Variation
3635.17
1225.62
471.09
735.41
(387.46)
(960.23)
773.22
1227.42
(813.78)
(713.95)
Mean Deviation
16.59
4.09
298.43
2.74
4.75
5.75
3.21
3.16
3.49
2.65
Jensen Alpha
1.44
0.35
157.8
1.6
(1.69)
(0.65)
0.3669
0.1946
(0.56)
(0.54)
Total Risk Alpha
(6.03)
(0.31)
58.31
0.0427
(2.67)
(1.96)
(0.02)
(0.21)
(1.31)
(1.03)
Sortino Ratio
0.0982
0.0533
3.23
0.6489
N/A
N/A
0.1452
0.0562
N/A
N/A
Downside Variance
233.18
53.08
2194.39
3.31
N/A
N/A
13.75
16.83
N/A
N/A
Standard Deviation
58.48
6.1
712.57
9.49
6.84
8.33
5.01
4.17
5.13
3.76
Kurtosis
59.21
4.8
23.32
61.22
2.58
4.99
13.69
1.21
4.42
4.65
Potential Upside
12.5
9.76
550.0
3.28
8.72
10.08
7.55
7.3
8.26
5.51
Treynor Ratio
1.03
0.3519
(2.30)
(0.39)
1.99
0.3809
0.2342
0.2425
0.7987
(33.15)
Maximum Drawdown
504.19
30.9
3997.5
82.36
40.76
50.96
37.89
22.8
35.86
26.91
Variance
3420.05
37.24
507759.06
90.08
46.82
69.4
25.09
17.42
26.33
14.15
Market Risk Adjusted Performance
1.04
0.3619
(2.29)
(0.38)
2.0
0.3909
0.2442
0.2525
0.8087
(33.14)
Risk Adjusted Performance
0.0309
0.071
0.1719
0.1129
(0.19)
(0.07)
0.1071
0.0703
(0.09)
(0.1)
Skewness
7.5
(1.11)
4.85
7.69
(0.68)
0.9068
2.55
(0.36)
(0.21)
(0.57)
Semi Deviation
13.99
6.4
27.98
0.37
N/A
N/A
3.27
3.87
N/A
N/A
Information Ratio
0.0256
0.0637
0.2121
0.1244
(0.27)
(0.12)
0.1075
0.0552
(0.14)
(0.17)
Value At Risk
(30.95)
(6.68)
(81.82)
(0.72)
(11.60)
(13.02)
(5.54)
(6.06)
(7.27)
(4.78)
Expected Short fall
(33.75)
(4.12)
(972.40)
(4.03)
N/A
N/A
(3.75)
(3.49)
N/A
N/A
Downside Deviation
15.27
7.29
46.84
1.82
N/A
N/A
3.71
4.1
N/A
N/A
Semi Variance
195.81
40.96
782.66
0.1369
N/A
N/A
10.67
15.0
N/A
N/A

Mallinckrodt Plc Competition Performance Charts

Five steps to successful analysis of Mallinckrodt Plc Competition

Mallinckrodt Plc's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Mallinckrodt Plc in relation to its competition. Mallinckrodt Plc's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Mallinckrodt Plc in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Mallinckrodt Plc's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Mallinckrodt Plc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Mallinckrodt Plc position

In addition to having Mallinckrodt Plc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cannabis Thematic Idea Now

Cannabis
Cannabis Theme
Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. The Cannabis theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cannabis Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Mallinckrodt Stock

If you are still planning to invest in Mallinckrodt Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mallinckrodt Plc's history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY